Novel SA53 MDM2 Inhibitor Therapy Has Potential to be a Breakthrough in Genetically-Targeted Cancer Treatment (CLEVELAND, OH) – Lamassu Biotech, a clinical-stage pharmaceutical company, today announced a significant clinical milestone...
Brothers Recognized for Their Pioneering Work in Cancer Treatment (CLEVELAND, OH) – Drs. Rabi and Gabi Hanna, two brothers who immigrated to the United States, now making pioneering strides in...
Health care technology is rapidly transforming how we prevent, diagnose and treat disease, and Northeast Ohio is at the forefront of this evolution. Read Crain's full feature, which includes Lamassu...